🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05922553
Recruiting Not applicable

Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer

NCT05922553 · tracked via the Priya Life Science China tracker
Sponsor
Wei XIA, PhD
Phase
Not applicable
Started
2024-12-16
Last updated
2025-08-06

Condition(s) studied

Children With Cancer

Investigational drug(s) / intervention(s)

Active Ingredient MukbangGeneral short videos

Active Ingredient Mukbang: Mukbang videos include the items which can truly improve the appetite of children with cancer, such as food images, eating sound and interactivity.

General short videos: Short videos that don't contain any food cues.

Study summary

This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.

Eligibility

Sex
ALL
Min age
6 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Aged between 6 to 18 years old; * Children in accordance with the guidelines for the Diagnosis and Treatment of 12 Diseases related to hematologic diseases and malignant tumors (2021 version) issued by the General Office of the National Health Commission; * At least experience one full cycle of chemotherapy; * Children with moderate or higher symptoms of decreased appetite were screened for a list of treatment-related symptoms. Exclusion Criteria: * Children with serious cardiopulmonary disease, infection, organ damage, or genetic metabolic disease, immune deficiency disease, mental illness; * Children with eye or ear dysfunction that prevents them from watching and listening to videos.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sun Yat-sen Memorial Hospital Guangzhou Guangdong Recruiting

More Wei XIA, PhD trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05922553 on ClinicalTrials.gov ↗ ← All trials in China